Literature DB >> 29397766

Trends in discharges from the HIV/AIDS ward at a tertiary Canadian Hospital from 2005 to 2014.

Denise Jaworsky1, Peter Phillips1,2,3, Zishan Cui2, William Chau2, Guillaume Colley2, Raja Dutta2, Benita Yip2, Hayden Kremer2, Oghenowede Eyawo2,4, Julio Sg Montaner1,2, Mark W Hull1,2.   

Abstract

Advances in HIV therapies have transformed HIV infection into a manageable chronic disease. Accordingly, hospital admission trends among people living with HIV may have evolved over time. This study describes discharge diagnoses from the dedicated HIV/AIDS ward at St. Paul's Hospital in Vancouver, Canada. A retrospective database review of admissions to the HIV/AIDS ward between 1 July 2005 and 30 June 2014 was conducted. Primary discharge diagnoses were manually categorized by condition and reviewed by two physicians. Data were analysed in 12-month intervals. Trends were fitted using generalized estimating equations. A total of 1595 individuals with 3919 admissions were included. The median age was 46 years, 77.1% identified as male, 63.6% had a history of injection drug use (IDU) and 61.8% had a history of hepatitis C virus exposure. The most common reasons for admission included non-opportunistic respiratory tract infections (18.2%), cellulitis (7.3%), gastroenteritis (6.0%), endocarditis/bacteremia (4.9%) and bone/joint infections (3.5%). The proportion of admissions attributable to opportunistic infections declined from 16.2% in 2005 to 5.5% in 2014. Over this period, the proportion of individuals on antiretroviral therapy and with virologic suppression increased (odds ratio 1.19 [95% confidence interval 1.16, 1.23] and 1.22 [95% confidence interval 1.17, 1.26], respectively). These results demonstrate a decline in admissions related to opportunistic infections but increased admissions due to other infections among people living with HIV. Preventive and outpatient care for respiratory infections and complications of IDU may further improve health care outcomes and decrease hospital admissions in this setting.

Entities:  

Keywords:  HIV/AIDS; cohort study; discharge diagnosis; highly active antiretroviral therapy; opportunistic infections

Mesh:

Year:  2018        PMID: 29397766     DOI: 10.1080/09540121.2018.1434121

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  3 in total

1.  Health programmes and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: a systematic integrative review.

Authors:  Katrina Bouzanis; Siddharth Joshi; Cynthia Lokker; Sureka Pavalagantharajah; Yun Qiu; Hargun Sidhu; Lawrence Mbuagbaw; Majdi Qutob; Alia Henedi; Mitchell A H Levine; Robin Lennox; Jean-Eric Tarride; Dale Kalina; Elizabeth Alvarez
Journal:  BMJ Open       Date:  2021-09-23       Impact factor: 3.006

2.  Infectious diseases, comorbidities and outcomes in hospitalized people who inject drugs (PWID) infections in persons who inject drugs.

Authors:  Jacqueline Lim; Sureka Pavalagantharajah; Chris P Verschoor; Eric Lentz; Mark Loeb; Mitchell Levine; Marek Smieja; Lawrence Mbuagbaw; Dale Kalina; Jean-Eric Tarride; Tim O'Shea; Anna Cvetkovic; Sarah van Gaalen; Aidan Reid Findlater; Robin Lennox; Carol Bassim; Cynthia Lokker; Elizabeth Alvarez
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.752

3.  Hospitalization Rates and Causes Among Persons With HIV in the United States and Canada, 2005-2015.

Authors:  Thibaut Davy-Mendez; Sonia Napravnik; Brenna C Hogan; Keri N Althoff; Kelly A Gebo; Richard D Moore; Michael A Horberg; Michael J Silverberg; M John Gill; Heidi M Crane; Vincent C Marconi; Ronald J Bosch; Jonathan A Colasanti; Timothy R Sterling; W Christopher Mathews; Angel M Mayor; Ni Gusti Ayu Nanditha; Kate Buchacz; Jun Li; Peter F Rebeiro; Jennifer E Thorne; Ank Nijhawan; David van Duin; David A Wohl; Joseph J Eron; Stephen A Berry
Journal:  J Infect Dis       Date:  2021-06-15       Impact factor: 5.226

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.